Related Experiment Videos
Transplantation for hepatocellular carcinoma
1Guy's, King's and St Thomas' School of Medicine, London, UK.
Seminars in Oncology
|October 31, 2001
Summary
Liver transplantation offers a viable treatment for hepatocellular carcinoma (HCC) when surgical resection isn't possible. This approach expands treatment options for HCC patients, especially those with limited hepatic reserve.
Area of Science:
- Hepatology
- Surgical Oncology
- Transplant Surgery
Background:
- Surgical resection for hepatocellular carcinoma (HCC) has strict eligibility criteria, including no metastatic or bilobar disease and adequate hepatic reserve.
- These criteria exclude over 70% of HCC patients from surgical resection due to associated severe liver disease.
Purpose of the Study:
- To discuss the role and indications of liver transplantation as a definitive therapy for hepatocellular carcinoma (HCC).
Main Methods:
- Review of existing literature on liver transplantation outcomes for HCC.
- Analysis of survival rates based on tumor size and number post-transplantation.
Main Results:
- Liver transplantation bypasses the strict criteria required for surgical resection, offering an alternative for more HCC patients.
- While large tumors (>5 cm) or multiple tumors (>4) are associated with lower survival rates, smaller tumors show significantly improved outcomes.
- Survival rates for select HCC patients undergoing transplantation may approach those seen in transplantation for nonmalignant liver conditions.
Conclusions:
- Liver transplantation is a crucial therapeutic option for eligible hepatocellular carcinoma patients who are not candidates for surgical resection.
- Careful patient selection and consideration of tumor burden are essential for optimizing outcomes in HCC transplantation.
- Further research into the long-term efficacy of transplantation for HCC is warranted.